Cure Cancer CEO Floyd Larsen to step down
It is with sadness that, last week, the Board of Cure Cancer Australia Foundation announced the departure of its Chief Executive Officer Floyd Larsen who is leaving to pursue an exciting private business opportunity.
Since joining Cure Cancer in 2015, Floyd has played a pivotal role in the transition of the organisation into a more dynamic, future-focused entity grounded in a shared commitment to make this the last generation to die from cancer.
Throughout her tenure, Floyd’s contribution has been significant. She has led the team in the development of more sustainable and predictable revenue streams and has been a champion of the use of innovative technologies and operational strategies that have helped us build a new generation of donors and supporters.
Speaking on behalf of the Board, Cure Cancer Chairman Philip Corne said, “Over the past three years, Floyd, through her energy, passion and tenacity has helped us become a forward-looking, technology-enabled organisation, well placed to continue our long-standing work in providing crucial financial support for Australia’s pioneering early career cancer researchers.
“Floyd leaves a strong management group and team that are well placed to carry through the critical work of Cure Cancer Australia. The Board would like to sincerely thank Floyd for her dedication and exceptional leadership and to offer our sincere best wishes as she leaves her role to pursue an exciting personal venture outside the not-for-profit space.”
Floyd will leave Cure Cancer later this month. A search for a new CEO is now in its final stages.